domingo, 24 de noviembre de 2013

Guillain-Barré Syndrome Surveillance during National Influenza Vaccination Campaign, New York, USA, 2009 - Vol. 19 No. 12 - December 2013 - Emerging Infectious Disease journal - CDC

full-text ►
Guillain-Barré Syndrome Surveillance during National Influenza Vaccination Campaign, New York, USA, 2009 - Vol. 19 No. 12 - December 2013 - Emerging Infectious Disease journal - CDC


Author or Reviewer Contact EID Announcements
December 2013 Issue Now Available Online

Volume 19, Number 12—December 2013

Research

Guillain-Barré Syndrome Surveillance during National Influenza Vaccination Campaign, New York, USA, 2009

Gregory P. Giambrone1Comments to Author , Shelley M. Zansky, Millicent Eidson, Pamela G. Duncan, Louise-Anne McNutt, and Guthrie S. Birkhead
Author affiliations: New York State Department of Health, Albany, New York, USA (G.P. Giambrone, S.M. Zansky, M. Eidson, P.G. Duncan, G.S. Birkhead); University at Albany School of Public Health, Rensselaer, New York, USA (L.-A. McNutt, G.S. Birkhead)
Suggested citation for this article

Abstract

The New York State Department of Health (NYSDOH) collected information about hospitalized patients with Guillain-Barré syndrome (GBS) during October 2009–May 2010, statewide (excluding New York City), to examine a possible relationship with influenza A(H1N1)pdm09 vaccination. NYSDOH established a Clinical Network of neurologists and 150 hospital neurology units. Hospital discharge data from the Statewide Planning and Research Cooperative System (SPARCS) were used to evaluate completeness of reporting from the Clinical Network. A total of 140 confirmed or probable GBS cases were identified: 81 (58%) from both systems, 10 (7%) from Clinical Network only, and 49 (35%) from SPARCS-only. Capture–recapture methods estimated that 6 cases might have been missed by both systems. Clinical Network median reporting time was 12 days versus 131 days for SPARCS. In public health emergencies in New York State, a Clinical Network may provide timely data, but in our study such data were less complete than traditional hospital discharge data.
In the fall of 1976, the outbreak of a swine-origin influenza virus prompted a mass vaccination campaign in the United States. Although an influenza epidemic did not occur, epidemiologic investigations demonstrated a small but significant risk for Guillain-Barré syndrome (GBS) among adult vaccine recipients within 6 weeks after vaccination (14). Some studies found that a relatively small risk extended slightly beyond the 6 weeks after vaccination (1,2). The estimated attributable risk for GBS after swine influenza vaccination was slightly less than 1 case per 100,000 persons vaccinated (1,3,4). Because of this association, GBS surveillance was established for the 3 subsequent influenza seasons; however, no increased risk for GBS was identified after influenza vaccination (5,6). The underlying reason for the association with the 1976 vaccination remains unknown.
In April 2009, influenza A(H1N1)pdm09 virus was first identified (79). Its emergence and rapid global spread prompted swift development of a new vaccine. The previous association of GBS with the 1976 vaccine raised concerns about the potential for a similar association with the new A(H1N1)pdm09 monovalent vaccines.
In June 2009, the Centers for Disease Control and Prevention (CDC) engaged the 10 CDC-funded Emerging Infection Program (EIP) sites (10,11), including New York State (NYS), to rapidly collect and report information about hospitalized persons with GBS during October 1, 2009–May 31, 2010, to examine a possible relationship with A(H1N1)pdm09 vaccines. Some participating sites had the capability to collect hospital discharge data in real time and used this method as a primary reporting source. However, NYS has inherently long delays in hospital discharge data reporting, so to conduct real-time surveillance, NYS established a network of practicing neurologists as primary reporters. Hospital discharge data were used to supplement and retrospectively evaluate the completeness of the active physician-based reporting system.
Results of the overall national EIP GBS surveillance system during the A(H1N1)pdm09 vaccination campaign, which includes NYS data from hospital discharge data and the physician-based reporting system, have been described (10,11). Because of the rarity of GBS and the small excess risk identified by multistate efforts associated with A(H1N1)pdm09 vaccines (10,11), the NYS Department of Health’s (NYSDOH) EIP did not attempt to study the association between vaccination and GBS. Presented here is a comprehensive evaluation of the NYSDOH EIP’s use of a neurologist-based reporting surveillance system. Capture–recapture was used to compare hospital discharge data with neurologist reports to evaluate the completeness of the overall NYSDOH surveillance system.



Acknowledgments

We thank Suzanne McGuire for her extraordinary work on the creation and maintenance of the internal database. We extend special thanks to all of our study nurses: Lisa Ayers, Casey Calabria, Mary Pat Boyle, Jennifer Hind, Gayle McNicholas, Katherine Montefusco, Brenda Naizby, Sandra Switzer, and Jeanine Woltmann, who tirelessly reviewed medical records to ensure the success of this surveillance activity. We also thank the neurology practices and hospital staff (primarily infection preventionists and medical records department staff) throughout NYS for their participation and patience.
This study was supported in part by CDC Cooperative Agreement no. U01-CI000311 and an appointment to the Applied Epidemiology Fellowship Program administered by the Council of State and Territorial Epidemiologists and funded by CDCCooperative Agreement no. 1U38HM000414.

References

  1. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, Keenlyside RA, Ziegler DW, Retailliau HF, Guillain-Barré syndrome following vaccination in the National Influenza Immunization Program, United States, 1976–1977. Am J Epidemiol. 1979;110:10523 .PubMedExternal Web Site Icon
  2. Langmuir AD, Bregman DJ, Kurland LT, Nathanson N, Victor M. An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines. Am J Epidemiol. 1984;119:84179 .PubMedExternal Web Site Icon
  3. Safranek TJ, Lawrence DN, Kurland LT, Culver DH, Wiederholt WC, Hayner NS, Reassessment of the association between Guillain-Barré syndrome and receipt of swine influenza vaccine in 1976–1977: results of a two-state study. Am J Epidemiol. 1991;133:94051 .PubMedExternal Web Site Icon
  4. Sejvar JJ, Pfeifer D, Schonberger LB. Guillain-Barré syndrome following influenza vaccination: causal or coincidental? Curr Infect Dis Rep. 2011;13:38798 . DOIExternal Web Site IconPubMedExternal Web Site Icon
  5. Hurwitz ES, Schonberger LB, Nelson DB, Holman RC. Guillain-Barré syndrome and the 1978–1979 influenza vaccine. N Engl J Med. 1981;304:155761. DOIExternal Web Site IconPubMedExternal Web Site Icon
  6. Kaplan JE, Katona P, Hurwitz ES, Schonberger LB. Guillain-Barré syndrome in the United States, 1979–1980 and 1980–1981. JAMA. 1982;248:698700. DOIExternal Web Site IconPubMedExternal Web Site Icon
  7. Centers for Disease Control and Prevention. Outbreak of swine-origin influenza A (H1N1) virus infection—Mexico, March–April 2009. MMWR Morb Mortal Wkly Rep. 2009;58:46770 .PubMedExternal Web Site Icon
  8. Centers for Disease Control and Prevention. Update: swine influenza A (H1N1) infections—California and Texas, April 2009. MMWR Morb Mortal Wkly Rep. 2009;58:4357 .PubMedExternal Web Site Icon
  9. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. Erratum in: N Engl J Med. 2009;361:102. N Engl J Med. 2009;360:2605–15.
  10. Wise ME, Viray M, Sejvar JJ, Lewis P, Baughman AL, Connor W, Guillain-Barré syndrome during the 2009–2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans. Am J Epidemiol. 2012;175:11109. DOIExternal Web Site IconPubMedExternal Web Site Icon
  11. Centers for Disease Control and Prevention. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine—United States, 2009–2010. MMWR Morb Mortal Wkly Rep. 2010;59:15 .PubMedExternal Web Site Icon
  12. Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29:599612. DOIExternal Web Site IconPubMedExternal Web Site Icon
  13. Hook EB, Regal RR. Capture–recapture methods in epidemiology: methods and limitations. Epidemiol Rev. 1995;17:24364 .PubMedExternal Web Site Icon
  14. Hook EB, Regal RR. Recommendations for presentation and evaluation of capture–recapture estimates in epidemiology. J Clin Epidemiol. 1999;52:91726 .PubMedExternal Web Site Icon
  15. Mastro TD, Kitayapon D, Weniger BG, Vanichseni S, Laosunthorn V, Uneklabh T, Estimating the number of HIV-infected injection drug users in Bangkok: a capture–recapture method. Am J Public Health. 1994;84:10949. DOIExternal Web Site IconPubMedExternal Web Site Icon
  16. Verstraeten T, Baughman AL, Cadwell B, Zanardi L, Haber P, Chen RT, Enhancing vaccine safety surveillance: a capture–recapture analysis of intussusception after rotavirus vaccination. Am J Epidemiol. 2001;154:100612. DOIExternal Web Site IconPubMedExternal Web Site Icon
  17. Wu C, Chang HG, McNutt LA, Smith PF. Estimating the mortality rate of hepatitis C using multiple data sources. Epidemiol Infect. 2005;133:1215. DOIExternal Web Site IconPubMedExternal Web Site Icon
  18. Huang WT, Huang WI, Huang YW, Hsu CW, Chuang JH. The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: a capture–recapture analysis. Vaccine. 2012;30:216872. DOIExternal Web Site IconPubMedExternal Web Site Icon
  19. Chapman DG. Some properties of the hypergeometric distribution with applications to zoological sample censuses. Berkeley (CA): University of California Publications in Statistics;1951. p.131–160.
  20. Seber GAF. The effects of trap response on tag recapture estimates. Biometrics. 1970;26:1322. DOIExternal Web Site Icon
  21. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:15974. DOIExternal Web Site IconPubMedExternal Web Site Icon
  22. Jajosky RA, Groseclose SL. Evaluation of reporting timeliness of public health surveillance systems for infectious diseases. BMC Public Health. 2004;4:29. DOIExternal Web Site IconPubMedExternal Web Site Icon
  23. German RR, Lee LM, Horan JM, Milstein RL, Pertowski CA, Waller MN, Updated guidelines for evaluating public health surveillance systems: recommendations from the guidelines working group. MMWR Recomm Rep. 2001;50(RR-13):135 .PubMedExternal Web Site Icon

Figure

Tables

Suggested citation for this article: Giambrone GP, Zansky SM, Eidson M, Duncan PG, McNutt L-A, Birkhead GS. Guillain-Barré syndrome surveillance during national influenza vaccination campaign, New York, USA, 2009. Emerg Infect Dis [Internet]. 2013 Dec [date cited]. http://dx.doi.org/10.3201/eid1912.130643External Web Site Icon
DOI: 10.3201/eid1912.130643
1Current affiliation: Weill Cornell Medical College, New York, New York, USA.

No hay comentarios:

Publicar un comentario